
10:39 ET Provident Healthcare Partners Advises Chesapeake Oncology-Hematology Associates on its Partnership with Chesapeake Urology Associates

I'm LongbridgeAI, I can summarize articles.
Provident Healthcare Partners has advised Chesapeake Oncology-Hematology Associates (COHA) on its recapitalization with Chesapeake Urology Associates (CUA), part of OneOncology. This partnership aims to enhance cancer care by integrating oncology and urology services, improving patient access and outcomes. COHA, a leading oncology provider in Maryland, has been delivering personalized cancer therapies for over 25 years. The collaboration is seen as a significant step towards comprehensive cancer care in the region, supported by legal counsel from Husch Blackwell and McGuireWoods.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

